{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:54:45Z","timestamp":1767707685024,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cyto.2020.155102","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T05:56:08Z","timestamp":1587016568000},"page":"155102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Interleukin-31 interaction with inflammasome: A promising diagnostic and prognostic panel for early sepsis identification in critically ill patients"],"prefix":"10.1016","volume":"131","author":[{"given":"Mona Mohamed","family":"Watany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maram Ibrahim","family":"Elmazny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham Mohamed","family":"Nasif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2020.155102_b0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1757-7241-17-67","article-title":"The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study","volume":"17","author":"Comstedt","year":"2009","journal-title":"Scand. J. Trauma Resusc. Emerg. Med."},{"key":"10.1016\/j.cyto.2020.155102_b0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2016.07.002","article-title":"Diagnosing sepsis \u2013 the role of laboratory medicine","volume":"460","author":"Fan","year":"2016","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"7625","key":"10.1016\/j.cyto.2020.155102_b0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/bmj.39346.495880.AE","article-title":"Sepsis: definition, epidemiology, and diagnosis","volume":"335","author":"Lever","year":"2007","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"3","key":"10.1016\/j.cyto.2020.155102_b0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcrc.2004.07.001","article-title":"Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis?","volume":"19","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.cyto.2020.155102_b0025","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor","volume":"255","author":"Gearing","year":"1992","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.cyto.2020.155102_b0030","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3858032","article-title":"IL-33\/IL-31 axis: a potential inflammatory pathway","volume":"2018","author":"Di Salvo","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.cyto.2020.155102_b0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jaci.2013.03.050","article-title":"Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation","volume":"132","author":"Stott","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"22","key":"10.1016\/j.cyto.2020.155102_b0040","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1111\/bph.12823","article-title":"Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice","volume":"171","author":"Kasutani","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155102_b0045","first-page":"171","article-title":"Effect of interleukin-31 on septic shock through regulating inflammasomes and interleukin-1\u03b2","volume":"16","author":"Gu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"5\u20136","key":"10.1016\/j.cyto.2020.155102_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cytogfr.2008.08.003","article-title":"Structures and biological functions of IL-31 and IL-31 receptors","volume":"19","author":"Zhang","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"issue":"41","key":"10.1016\/j.cyto.2020.155102_b0055","doi-asserted-by":"crossref","first-page":"24747","DOI":"10.1074\/jbc.M115.661306","article-title":"Prerequisites for functional interleukin 31 signaling and its feedback regulation by suppressor of cytokine signaling 3 (SOCS3)","volume":"290","author":"Maier","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2020.155102_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170446","article-title":"Correction: IL-31-driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin-barrier function","volume":"12","author":"Singh","year":"2017","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.cyto.2020.155102_b0065","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1172\/JCI71543","article-title":"Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies","volume":"123","author":"Brydges","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.cyto.2020.155102_b0070","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.cyto.2020.155102_b0075","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2020.155102_b0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1beta and IL-18 processing during infection","volume":"32","author":"van de Veerdonk","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155102_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1412-9","article-title":"The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding","volume":"10","author":"Mouasni","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cyto.2020.155102_b0090","doi-asserted-by":"crossref","first-page":"31397","DOI":"10.1155\/2007\/31397","article-title":"Serum IL-1beta, IL-6, IL-8, and TNF-alpha levels in early diagnosis and management of neonatal sepsis","volume":"2007","author":"Kurt","year":"2007","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.cyto.2020.155102_b0095","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.1801089","article-title":"Cutting edge: IL-1\u03b1 and not IL-1\u03b2 drives IL-1R1\u2013dependent neonatal murine sepsis lethality","volume":"201","author":"Benjamin","year":"2018","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155102_b0100","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.201604-0892OC","article-title":"NLRP3 inflammasome deficiency protects against microbial sepsis via increased lipoxin B4 synthesis","volume":"196","author":"Lee","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.cyto.2020.155102_b0105","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.1601745","article-title":"Deletion of Nlrp3 augments survival during polymicrobial sepsis by decreasing autophagy and enhancing phagocytosis","volume":"198","author":"Jin","year":"2017","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.cyto.2020.155102_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01687","article-title":"Platelets in sepsis: an update on experimental models and clinical data","volume":"10","author":"Assinger","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2020.155102_b0115","article-title":"Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.cyto.2020.155102_b0120","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1096\/fj.201600728R","article-title":"Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis","volume":"30","author":"Kalbitz","year":"2016","journal-title":"FASEB J.: Off. Publ. Fed. Am. Societ. Exp. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2020.155102_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46116-9","article-title":"Pro-inflammatory role of NLRP3 inflammasome in experimental sterile corneal inflammation","volume":"9","author":"Shimizu","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cyto.2020.155102_b0130","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2020.155102_b0135","first-page":"1089107","article-title":"Diagnosis and prognosis of sepsis based on use of cytokines","volume":"2019","author":"Jekarl","year":"2019","journal-title":"Chemokines Growth Fact. Dis. Mark."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620301186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620301186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:13Z","timestamp":1760907313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620301186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":27,"alternative-id":["S1043466620301186"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155102","relation":{},"ISSN":["1043-4666"],"issn-type":[{"type":"print","value":"1043-4666"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-31 interaction with inflammasome: A promising diagnostic and prognostic panel for early sepsis identification in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155102"}}